Misonix, Inc., a surgical device company, has received a new US patent on the company's medical device products. The patent describes a means to control the output of various powered surgical devices such that power can be applied only at times where the tool is translated forward in the operative site and not at other times.

By limiting power on to only the time required, tissue heating is reduced thereby improving procedure outcome and enhancing safety along with surgeon ergonomics. This action does not require the surgeon to activate switches or other mechanical means so that the action is transparent to the user.

To date this year, six patents have been issued to Misonix, many of which apply to the Company's ultrasonic platform in general and to its BoneScalpel product.

Michael A McManus, junior president and CEO of Misonix stated, "Misonix continues to grow and protect its core technology through continued intellectual property development and patent submissions. We believe our unique application of Ultrasound technology is one of our great assets which will continue to create growth opportunities and value going forward."

Misonix, Inc. designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications.